Latest Stem Cells news
Non-Hispanic Black Patients Have Disparities in HCT Use for Hematologic Cancers
posted September 26th
by modernClinician Editorial Team
by modernClinician Editorial Team
Lung Function Stable Three Years After Hematopoietic Cell Transplant in Sickle Cell
posted September 5th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Darzalex Faspro for Treating Multiple Myeloma
posted August 7th
by modernClinician Editorial Team
by modernClinician Editorial Team
Socioeconomic Status of Stem Cell Donor Affects Recipient Health Outcomes
posted July 25th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Obesity Linked to Early-Onset Cancer Risk in Young Adults 
Response to Autologous HSCT Durable for Patients With Systemic Sclerosis .jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
Personalized Support Boosts Families" Genetic Testing for Hereditary Cancers Related Articles
Stem Cell Treatment Feasible for Aniridia-Related Keratopathy 
Patient Education Increases Skin Cancer Screening in Stem Cell Transplant Survivors 
Indefinite-Duration Maintenance Therapy No Better Than Fixed-Duration Therapy in Multiple Myeloma 
Definition of Functional High-Risk Multiple Myeloma Updated in Era of Combo Therapy Monthly Specialist Briefings
Stay Connected
